vs
ACNB CORP（ACNB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ACNB CORP的1.6倍（$75.5M vs $47.2M），ACNB CORP同比增速更快（42.2% vs 27.7%），ACNB CORP自由现金流更多（$52.6M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 22.1%）
ACNB集团是总部位于美国宾夕法尼亚州的金融控股公司，提供零售及商业银行服务、财富管理、信托服务、财产及意外伤害保险等金融产品，主要服务宾夕法尼亚州中南部、马里兰州北部的当地居民及中小企业客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ACNB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$47.2M
营收增速更快
ACNB
高出14.5%
27.7%
自由现金流更多
ACNB
多$38.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
22.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.2M | $75.5M |
| 净利润 | $10.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 27.9% | 22.7% |
| 净利率 | 22.9% | — |
| 营收同比 | 42.2% | 27.7% |
| 净利润同比 | 63.8% | — |
| 每股收益（稀释后） | $1.10 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACNBPBYI
| Q4 25 | $47.2M | $75.5M | ||
| Q3 25 | $50.9M | $54.5M | ||
| Q2 25 | $50.3M | $52.4M | ||
| Q1 25 | $43.5M | $46.0M | ||
| Q4 24 | $33.2M | $59.1M | ||
| Q3 24 | $34.1M | $80.5M | ||
| Q2 24 | $33.3M | $47.1M | ||
| Q1 24 | $31.6M | $43.8M |
净利润ACNBPBYI
| Q4 25 | $10.8M | — | ||
| Q3 25 | $14.9M | $8.8M | ||
| Q2 25 | $11.6M | $5.9M | ||
| Q1 25 | $-272.0K | $3.0M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $7.2M | $20.3M | ||
| Q2 24 | $11.3M | $-4.5M | ||
| Q1 24 | $6.8M | $-4.8M |
毛利率ACNBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ACNBPBYI
| Q4 25 | 27.9% | 22.7% | ||
| Q3 25 | 37.2% | 17.6% | ||
| Q2 25 | 29.7% | 12.7% | ||
| Q1 25 | -1.3% | 8.7% | ||
| Q4 24 | 24.8% | 22.6% | ||
| Q3 24 | 27.6% | 27.4% | ||
| Q2 24 | 42.8% | -4.6% | ||
| Q1 24 | 26.9% | -5.3% |
净利率ACNBPBYI
| Q4 25 | 22.9% | — | ||
| Q3 25 | 29.2% | 16.2% | ||
| Q2 25 | 23.2% | 11.2% | ||
| Q1 25 | -0.6% | 6.5% | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 21.1% | 25.2% | ||
| Q2 24 | 33.9% | -9.6% | ||
| Q1 24 | 21.4% | -11.0% |
每股收益（稀释后）ACNBPBYI
| Q4 25 | $1.10 | $0.26 | ||
| Q3 25 | $1.42 | $0.17 | ||
| Q2 25 | $1.11 | $0.12 | ||
| Q1 25 | $-0.03 | $0.06 | ||
| Q4 24 | $0.77 | $0.40 | ||
| Q3 24 | $0.84 | $0.41 | ||
| Q2 24 | $1.32 | $-0.09 | ||
| Q1 24 | $0.80 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.6M | $97.5M |
| 总债务越低越好 | $255.4M | $22.7M |
| 股东权益账面价值 | $420.0M | $130.3M |
| 总资产 | $3.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.61× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ACNBPBYI
| Q4 25 | $65.6M | $97.5M | ||
| Q3 25 | $102.1M | $94.4M | ||
| Q2 25 | $103.1M | $96.0M | ||
| Q1 25 | $123.6M | $93.2M | ||
| Q4 24 | $47.3M | $101.0M | ||
| Q3 24 | $58.1M | $96.7M | ||
| Q2 24 | $86.3M | $96.8M | ||
| Q1 24 | $53.1M | $107.2M |
总债务ACNBPBYI
| Q4 25 | $255.4M | $22.7M | ||
| Q3 25 | $255.4M | $34.0M | ||
| Q2 25 | $255.4M | $45.3M | ||
| Q1 25 | $255.3M | $56.7M | ||
| Q4 24 | $255.3M | $68.0M | ||
| Q3 24 | $255.3M | $79.3M | ||
| Q2 24 | $255.3M | $90.7M | ||
| Q1 24 | $255.3M | $102.0M |
股东权益ACNBPBYI
| Q4 25 | $420.0M | $130.3M | ||
| Q3 25 | $408.6M | $115.3M | ||
| Q2 25 | $395.2M | $104.7M | ||
| Q1 25 | $386.9M | $97.1M | ||
| Q4 24 | $303.3M | $92.1M | ||
| Q3 24 | $306.8M | $71.1M | ||
| Q2 24 | $289.3M | $48.5M | ||
| Q1 24 | $279.9M | $51.0M |
总资产ACNBPBYI
| Q4 25 | $3.2B | $216.3M | ||
| Q3 25 | $3.3B | $202.9M | ||
| Q2 25 | $3.3B | $194.9M | ||
| Q1 25 | $3.3B | $196.2M | ||
| Q4 24 | $2.4B | $213.3M | ||
| Q3 24 | $2.4B | $220.7M | ||
| Q2 24 | $2.5B | $205.0M | ||
| Q1 24 | $2.4B | $214.1M |
负债/权益比ACNBPBYI
| Q4 25 | 0.61× | 0.17× | ||
| Q3 25 | 0.62× | 0.30× | ||
| Q2 25 | 0.65× | 0.43× | ||
| Q1 25 | 0.66× | 0.58× | ||
| Q4 24 | 0.84× | 0.74× | ||
| Q3 24 | 0.83× | 1.12× | ||
| Q2 24 | 0.88× | 1.87× | ||
| Q1 24 | 0.91× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $52.6M | $14.4M |
| 自由现金流率自由现金流/营收 | 111.4% | 19.1% |
| 资本支出强度资本支出/营收 | 2.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.96× | — |
| 过去12个月自由现金流最近4个季度 | $92.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ACNBPBYI
| Q4 25 | $53.6M | $14.4M | ||
| Q3 25 | $23.2M | $9.7M | ||
| Q2 25 | $17.8M | $14.1M | ||
| Q1 25 | $-71.0K | $3.6M | ||
| Q4 24 | $39.8M | $15.6M | ||
| Q3 24 | $13.6M | $11.0M | ||
| Q2 24 | $9.7M | $1.0M | ||
| Q1 24 | $10.8M | $11.2M |
自由现金流ACNBPBYI
| Q4 25 | $52.6M | $14.4M | ||
| Q3 25 | $22.8M | $9.7M | ||
| Q2 25 | $17.6M | $14.1M | ||
| Q1 25 | $-730.0K | $3.6M | ||
| Q4 24 | $38.8M | $15.6M | ||
| Q3 24 | $13.3M | $11.0M | ||
| Q2 24 | $9.4M | $1.0M | ||
| Q1 24 | $10.7M | — |
自由现金流率ACNBPBYI
| Q4 25 | 111.4% | 19.1% | ||
| Q3 25 | 44.7% | 17.7% | ||
| Q2 25 | 35.0% | 26.8% | ||
| Q1 25 | -1.7% | 7.7% | ||
| Q4 24 | 117.0% | 26.4% | ||
| Q3 24 | 39.1% | 13.7% | ||
| Q2 24 | 28.3% | 2.1% | ||
| Q1 24 | 33.9% | — |
资本支出强度ACNBPBYI
| Q4 25 | 2.3% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 2.9% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率ACNBPBYI
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | 1.10× | ||
| Q2 25 | 1.52× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | 0.54× | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
